Download Download Flyer

Approved April 30, 2012
DO YOU SMOKE?
A NIH-funded research project is being done to learn more about how
nicotine and the medication Varenicline affect the brain and behavior.
Varenicline is FDA-approved for smoking cessation treatment
and marketed as Chantix, a drug used to help people quit smoking.
We also want to learn more about the genetic and environmental risk factors
for nicotine addiction.
The study requires 3 visits, 1 of which includes staying on the research unit
at Johns Hopkins Hospital for 6 nights.
Compensation up to $695 will be provided for study completion.
For more information:
IPSAR
410.502-5433
JOHNS HOPKINS MEDICINE
Principal Investigator: Mary E. McCaul, PhD
Protocol # NA_00031348